Understanding Multiple Sclerosis
Multiple Sclerosis is a chronic autoimmune disease that affects the central nervous system. It occurs when the immune system mistakenly attacks the protective covering of nerve fibers, known as myelin, in the brain and spinal cord. This damage disrupts the normal flow of electrical impulses along the nerves, leading to a wide range of symptoms such as fatigue, muscle weakness, and difficulty with coordination and balance.
Introduction to Gilenya
Gilenya, also known as Fingolimod, is an FDA-approved oral medication for the treatment of relapsing forms of Multiple Sclerosis. It belongs to a class of drugs called sphingosine 1-phosphate receptor modulators. This medication works by binding to specific receptors on immune cells, preventing them from entering the central nervous system. By keeping the immune cells in the bloodstream, Gilenya helps reduce the inflammation and damage caused by the immune system in the brain and spinal cord. It is important to note that Gilenya does not cure Multiple Sclerosis, but it can help control the symptoms and slow down the progression of the disease.
Administration and Dosage
Gilenya is available in the form of capsules that are taken orally. The recommended dosage of Gilenya for adults with relapsing forms of Multiple Sclerosis is 0.5 mg once daily. It is important to follow the prescribed dosage and instructions provided by the healthcare provider. Regular monitoring of blood pressure, heart rate, and eye exams may be required during the treatment with Gilenya.
Safety and Side Effects
Like any medication, Gilenya may cause side effects in some individuals. Common side effects include headache, diarrhea, cough, back pain, and abnormal liver function tests. Serious side effects such as slowed heart rate, macular edema (swelling of the central part of the retina), and increased risk of infection may occur. It is important to discuss any concerns or symptoms with the healthcare provider to ensure the safe use of Gilenya.